China’s Youth Face a Split Metabolic Fate as Obesity and Diabetes Surge

A sweeping analysis of three decades of health data has revealed a deeply divided metabolic picture among China’s children, adolescents, and young adults. While the burden of high blood pressure in people aged 5 to 24 has fallen steadily since 1990, the toll of obesity and type 2 diabetes has climbed sharply, and a once-declining epidemic of fatty liver disease has quietly reversed course since the middle of the last decade. The findings, drawn from the Global Burden of Disease Study 2021 and published in Pediatric Research, offer one of the most detailed long-term portraits yet of how rapid economic and social transformation has reshaped the metabolic health of an entire generation of young Chinese.

The research team, led by Hongxia Liu and Yan Wang of the Department of Pediatrics at Henan Provincial People’s Hospital, affiliated with People’s Hospital of Zhengzhou University, set out to address a persistent gap in the literature. Socioeconomic shifts in China have clearly driven an increase in metabolic disorders, but long-term trend data specifically covering youth aged 5 to 24 have remained scarce. Most existing studies focus either on adults or on very young children, leaving adolescents and young adults in a statistical blind spot even though habits formed in these years often persist for life. By analyzing the full 1990 to 2021 period, the researchers could capture the entire arc of China’s extraordinary development, from the early years of market reform through urbanization, dietary change, and the digital era.

At the heart of the study is a metric called the disability-adjusted life year, or DALY, which combines years of life lost to premature death with years lived in disability or ill health. One DALY represents one lost healthy year. By calculating age-standardized DALY rates, abbreviated ASDR, the investigators could compare disease burden across years and populations while accounting for shifts in the age structure of the population. The team focused on four conditions: hypertension, non-alcoholic fatty liver disease, obesity, and type 2 diabetes mellitus. Each of these was once considered an affliction of middle age, yet all four now appear, with varying frequency, among people in their teens and twenties.

The analytical toolkit was considerable. To detect changes in trajectory rather than assuming smooth linear trends, the researchers used Joinpoint regression, a statistical technique originally developed for cancer surveillance that identifies the years at which a trend’s direction or steepness shifts significantly. From these turning points they calculated average annual percentage changes, or AAPCs, which quantify how fast the burden rose or fell. To look forward, they applied a Bayesian age-period cohort model, a probabilistic framework that disentangles the effects of age, calendar time, and birth cohort on disease rates and uses that structure to generate forecasts. Finally, a decomposition analysis partitioned the observed changes in DALYs into three contributing forces: changes in disease rates themselves, population growth, and population aging.

The results tell a story of divergence. Hypertension showed the most encouraging trajectory, with its age-standardized DALY rate falling at an average annual rate of 2.89 percent, a decline that outpaced the global average for the same age group. This improvement, the authors suggest, reflects decades of public health investment, including national salt-reduction awareness efforts and the screening programs embedded in school health services. Yet even this success is incomplete, because hypertension in youth often goes undetected and untreated, silently seeding cardiovascular risk for later life.

Obesity and type 2 diabetes moved in the opposite direction. The age-standardized DALY rate for obesity climbed at an average annual rate of 3.06 percent, while the rate for type 2 diabetes rose at 3.12 percent, both consistent with the upward trends observed globally. These figures align with a broader body of evidence documenting the rapid rise of childhood overweight and obesity in China, driven by increased consumption of sugar-sweetened beverages, ultra-processed foods, and energy-dense diets, alongside a documented decline in physical activity and a surge in sedentary screen time among children and adolescents. The link between early obesity and early-onset type 2 diabetes is well established: excess adiposity in childhood promotes insulin resistance, and the pancreatic beta cells, stressed for years, begin to fail decades earlier than in previous generations. A condition that was once almost unheard of in teenagers is now a recognized pediatric diagnosis in China, prompting the Chinese Medical Association to issue dedicated consensus guidance on managing type 2 diabetes in children and adolescents.

Non-alcoholic fatty liver disease, a condition in which fat accumulates in the liver of someone who drinks little or no alcohol, presented the most nuanced pattern. Across the full 32-year window, its DALY rate declined at an average annual rate of 1.84 percent. But the Joinpoint analysis revealed that this decline was not uniform: after the mid-2010s, the burden rebounded, and the resurgence was particularly pronounced among females. This reversal matters because hepatic steatosis in childhood is increasingly recognized as a marker of broader metabolic risk, and fatty liver disease in the presence of insulin resistance can progress toward inflammation, fibrosis, and, in the long term, cirrhosis and liver cancer. The authors emphasize that this recent resurgence among young women demands targeted attention, and they note that awareness of the condition remains low even among young adults, a gap that randomized intervention trials in China have attempted to close through education campaigns aimed at prevention.

Sex differences emerged as a consistent theme throughout the analysis. Males bore a higher proportion of DALYs across the metabolic conditions studied, a pattern that echoes physiological and behavioral research on why men accumulate more abdominal visceral fat, the metabolically active depot most strongly linked to insulin resistance and cardiovascular risk. Behavioral factors compound the biology: smoking initiation in adolescence remains common among Chinese males, and smoking interacts with metabolic disease in ways that accelerate vascular damage. At the same time, the female-specific rebound in fatty liver disease highlights that risk is not distributed simply, and the authors argue explicitly for sex-specific public health strategies rather than one-size-fits-all interventions.

The decomposition analysis added a crucial interpretive layer. It showed that the increases in DALYs were driven primarily by epidemiological change, meaning shifts in the underlying rates of disease themselves, rather than by demographic forces. Population growth and population aging actually exerted mitigating effects on the age-standardized burden, underscoring that the worsening picture is not an artifact of there simply being more young people. The diseases themselves are becoming more common relative to population size, which makes the trend harder to dismiss and more consequential for health planning.

Looking ahead, the Bayesian projections to 2030 extend the bifurcation into the coming decade. Hypertension is forecast to continue improving, but obesity and type 2 diabetes are predicted to worsen, placing an expanding burden on young people precisely at the ages when they enter the workforce and begin families. The findings arrive as China pursues national frameworks including the Outline for Building a Healthy China 2030, the National Nutrition Plan, and dedicated policies on weight control among children and adolescents and on strengthening school physical education. The study’s message to policymakers is that these frameworks must be sharpened and targeted: the hypertension gains show that sustained intervention works, while the relentless rise of obesity and diabetes shows where the next battle lies. Without urgent, sex-aware, and age-tailored action, a generation of young Chinese faces a future in which the chronic diseases of adulthood arrive decades early.

Subject of Research: Long-term trends in the burden of hypertension, obesity, type 2 diabetes, and fatty liver disease among Chinese youth aged 5 to 24 from 1990 to 2021

Article Title: The burden of metabolic diseases in Chinese youth, 1990–2021: a Global Burden of Disease Study 2021

Article References: Liu, H., Zhang, B., Ma, C., Sun, X., Gao, L., & Wang, Y. (2026). The burden of metabolic diseases in Chinese youth, 1990–2021: a Global Burden of Disease Study 2021. Pediatric Research. https://doi.org/10.1038/s41390-026-05311-x

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05311-x

Keywords: Global Burden of Disease, Chinese youth, obesity, type 2 diabetes, hypertension, non-alcoholic fatty liver disease, DALY, pediatric metabolic health, sex disparities, Bayesian projection, public health, epidemiology